MedPath
HSA Approval

FLUCONAZOLE KABI SOLUTION FOR INFUSION 2MG/ML

SIN15044P

FLUCONAZOLE KABI SOLUTION FOR INFUSION 2MG/ML

FLUCONAZOLE KABI SOLUTION FOR INFUSION 2MG/ML

July 4, 2016

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

J02AC01

fluconazole

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi Poland Sp. Z o.o.

Active Ingredients

FLUCONAZOLE

2mg/ml

Fluconazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FLUCONAZOLE KABI SOLUTION FOR INFUSION 2MG/ML - HSA Approval | MedPath